CGCIX | CIREX | CGCIX / CIREX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 23 years | - |
Gain YTD | 0.868 | 1.421 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 285M | 107B | 0% |
Annual Yield % from dividends | 0.76 | 3.02 | 25% |
Returns for 1 year | 15.41 | 10.45 | 147% |
Returns for 3 years | 8.09 | 9.38 | 86% |
Returns for 5 years | 39.45 | 27.61 | 143% |
Returns for 10 years | 56.78 | 59.94 | 95% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OTPSX | 35.12 | 0.57 | +1.65% |
ProFunds NASDAQ-100 Svc | |||
SBQAX | 14.03 | 0.08 | +0.57% |
DSS AmericaFirst Large Cap Shr Buyback A | |||
GDSRX | 25.53 | 0.11 | +0.43% |
Goldman Sachs Small Cap Eq Insghts R | |||
DVLRX | 64.67 | 0.21 | +0.33% |
Macquarie Small Cap Value R | |||
FPHAX | 24.48 | -0.59 | -2.35% |
Fidelity Select Pharmaceuticals Port |